Eisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) shares crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $61.51 and traded as high as $63.29. Eisai shares last traded at $61.51, with a volume of 331,800 shares.
Eisai Stock Down 2.1%
The firm’s fifty day simple moving average is $61.51 and its 200-day simple moving average is $61.51. The company has a market cap of $17.64 billion, a PE ratio of 70.70, a P/E/G ratio of 2.46 and a beta of 0.31. The company has a quick ratio of 1.77, a current ratio of 2.20 and a debt-to-equity ratio of 0.10.
Eisai Company Profile
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Further Reading
- Five stocks we like better than Eisai
- 3 Energy Stocks Raising Dividends as the Sector Surges
- 5 Reasons the S&P 500 Could Keep Rallying Through Year-End
- Walmart’s Post-Earnings Drop Could Be a Buying Opportunity
- The Trade Desk’s Earnings Miss Raises a Bigger Question About Its AI Future
Receive News & Ratings for Eisai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eisai and related companies with MarketBeat.com's FREE daily email newsletter.
